Yüklüyor......
Activation of PKC isoform β(I) at the blood–brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the pharmacotherapy of central nervous system diseases, including brain tumors, neuro-AIDS, and epilepsy. Previous studies have shown...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2949219/ https://ncbi.nlm.nih.gov/pubmed/20197783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2010.21 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|